We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-1.67%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$30.7B
AUM Growth
-$1.16B
Cap. Flow
-$167M
Cap. Flow %
-0.54%
Top 10 Hldgs %
37.44%
Holding
630
New
71
Increased
203
Reduced
261
Closed
60

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$352M
2
UNH icon
UnitedHealth
UNH
+$216M
3
STZ icon
Constellation Brands
STZ
+$175M
4
ELV icon
Elevance Health
ELV
+$132M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$129M

Top Sells

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$229M
2
ISRG icon
Intuitive Surgical
ISRG
+$226M
3
KO icon
Coca-Cola
KO
+$138M
4
WFC icon
Wells Fargo
WFC
+$76.7M
5
META icon
Meta Platforms (Facebook)
META
+$73.3M

Sector Composition

Rank Sector Weight
1 Technology 29.53%
2 Healthcare 23.35%
3 Financials 11.26%
4 Communication Services 10.36%
5 Consumer Discretionary 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$1.65B 5.37%
3,916,877
-84,978
-2% -$36.2M
AAPL icon
2
Apple
AAPL
$4.72T
$1.58B 5.14%
6,313,992
-26,035
-0.4% -$6.14M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$3.89T
$1.4B 4.55%
7,381,918
+52,896
+0.7% +$9.26M
META icon
4
Meta Platforms (Facebook)
META
$1.54T
$1.3B 4.23%
2,222,257
-124,809
-5% -$73.3M
UNH icon
5
UnitedHealth
UNH
$385B
$1.05B 3.41%
2,070,968
+380,459
+23% +$216M
ORCL icon
6
Oracle
ORCL
$346B
$980M 3.19%
5,881,993
-135,408
-2% -$24.1M
V icon
7
Visa
V
$669B
$935M 3.04%
2,956,929
+35,709
+1% +$10.7M
JNJ icon
8
Johnson & Johnson
JNJ
$624B
$920M 2.99%
6,360,243
+66,206
+1% +$10.3M
ABT icon
9
Abbott
ABT
$175B
$893M 2.91%
7,896,939
+787,251
+11% +$91M
TXN icon
10
Texas Instruments
TXN
$260B
$804M 2.62%
4,289,156
+43,483
+1% +$8.69M
ACN icon
11
Accenture
ACN
$84.9B
$785M 2.55%
2,231,287
+46,073
+2% +$16.6M
CRM icon
12
Salesforce
CRM
$129B
$743M 2.42%
2,222,913
-35,400
-2% -$11.3M
ELV icon
13
Elevance Health
ELV
$82.3B
$738M 2.4%
2,000,660
+316,002
+19% +$132M
AMZN icon
14
Amazon
AMZN
$2.51T
$706M 2.3%
3,216,603
-336,082
-9% -$68.8M
USB icon
15
US Bancorp
USB
$98.7B
$619M 2.01%
12,935,847
+120,543
+0.9% +$5.93M
MRK icon
16
Merck
MRK
$322B
$613M 2%
6,165,271
+253,227
+4% +$26.1M
WFC icon
17
Wells Fargo
WFC
$261B
$613M 1.99%
8,729,358
-1,123,890
-11% -$76.7M
KO icon
18
Coca-Cola
KO
$349B
$589M 1.92%
9,460,668
-2,113,796
-18% -$138M
LRCX icon
19
Lam Research
LRCX
$400B
$585M 1.9%
8,097,665
-325
-0% -$24.7K
TMO icon
20
Thermo Fisher Scientific
TMO
$213B
$569M 1.85%
1,093,866
+639,467
+141% +$352M
ISRG icon
21
Intuitive Surgical
ISRG
$119B
$555M 1.81%
1,063,470
-433,844
-29% -$226M
STZ icon
22
Constellation Brands
STZ
$22.1B
$542M 1.76%
2,454,258
+736,780
+43% +$175M
HLT icon
23
Hilton Worldwide
HLT
$72.9B
$490M 1.59%
1,983,220
+350,748
+21% +$85.8M
OTIS icon
24
Otis Worldwide
OTIS
$27.2B
$478M 1.55%
5,159,105
+60,564
+1% +$6.07M
TJX icon
25
TJX Companies
TJX
$170B
$456M 1.48%
3,773,923
-1,920,938
-34% -$229M
1
2 3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2024 Portfolio in Review

As of Q4 2024, Grantham, Mayo, Van Otterloo & Co (GMO) held 630 positions worth $30.7B, down 3.6% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q4 2024 filing shows 71 new, 203 increased, 261 reduced and 60 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 218,200 shares worth $128M. The largest sale was TJX Companies, an estimated $229M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q4 2024 buy was iShares Core S&P 500 ETF: 218,200 shares worth $128M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Thermo Fisher Scientific in Q4 2024, an estimated $352M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q4 2024 reduction was TJX Companies, cutting an estimated $229M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $38.4M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 37% of its $30.7B portfolio in Q4 2024.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 71 new positions and closed 60 in Q4 2024.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 3.6% quarter-over-quarter to $30.7B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2024, filed 13 Feb 2025.